This training grant provides research training that will allow MD, PhD, and MD/PhD postdoctoral fellows to become independent investigators in the fields of diabetes, obesity, and metabolism. Research training will be provided by a large group of highly-skilled and experienced investigators, from the University of Washington and affiliated institutions, who will serve as preceptors. Based on 1) the continued outstanding success of this program and large numbers of applicants, 2) a major commitment from the University of Washington to create and support a Diabetes and Obesity Center of Excellence in a new research campus, 3) revamped didactic training and oversight and 4) an infusion of new program faculty, including a number of new clinical and translational researchers, we request continued funding of six postdoctoral training positions. In addition, we are requesting six predoctoral positions to support students enrolled in the NIDDK Medical Student Research Program in Diabetes which provides three months of training to eligible medical students. MD candidates will have completed residency training as well as a first, clinical year of fellowship prior to funding by this program. This arrangement allows both MD and PhD fellows to spend a minimum of 80% of their time on research activities while they are supported by this training grant. Fellow applicants will be chosen by the Fellowship Training Executive Committee from a large pool of qualified candidates who apply to the Division of Metabolism, Endocrinology and Nutrition at the University of Washington for their research training. Among the criteria for selection are 1) a strong interest in the fields of diabetes, obesity and glucose or energy metabolism (frequently accompanied by previous research experience), and 2) a demonstrated potential for a successful research career. This program provides trainees with research experience in both basic and clinical aspects of diabetes and obesity, with special emphasis on molecular and cell biology, physiology, and translational research. Research training will be complemented by didactic lectures and seminars that cover diabetes, obesity, glucose homeostasis, energy metabolism and related aspects of endocrinology, with additional coursework in scientific methods, manuscript preparation, grantsmanship, and biomedical ethics. Diabetes and obesity are among our most pressing public health concerns. Despite impressive advances at the basic science level, major unanswered questions regarding the pathogenesis of these disorders continue to limit our capacity to treat them. Effective training fo scientists in diabetes and obesity are therefore fundamental priorities.

Public Health Relevance

Diabetes and obesity are among the most pressing public health concerns. Despite impressive advances at the basic science level, major unanswered questions regarding the pathogenesis of these disorders continue to limit our capacity to treat them. Effective training for scientists in diabetes, obesity and metabolic regulation are therefore fundamental priorities.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Institutional National Research Service Award (T32)
Project #
5T32DK007247-37
Application #
8686816
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
1977-07-01
Project End
2018-06-30
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
37
Fiscal Year
2014
Total Cost
$355,283
Indirect Cost
$30,614
Name
University of Washington
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Surampudi, P; Page, S T; Swerdloff, R S et al. (2014) Single, escalating dose pharmacokinetics, safety and food effects of a new oral androgen dimethandrolone undecanoate in man: a prototype oral male hormonal contraceptive. Andrology 2:579-87
Chao, Jing; Page, Stephanie T; Anderson, Richard A (2014) Male contraception. Best Pract Res Clin Obstet Gynaecol 28:845-57
Berkseth, Kathryn E; Guyenet, Stephan J; Melhorn, Susan J et al. (2014) Hypothalamic gliosis associated with high-fat diet feeding is reversible in mice: a combined immunohistochemical and magnetic resonance imaging study. Endocrinology 155:2858-67
Utzschneider, Kristina M; Largajolli, Anna; Bertoldo, Alessandra et al. (2014) Serum ferritin is associated with non-alcoholic fatty liver disease and decreased ýý-cell function in non-diabetic men and women. J Diabetes Complications 28:177-84
Ho, Jacqueline M; Anekonda, Vishwanath T; Thompson, Benjamin W et al. (2014) Hindbrain oxytocin receptors contribute to the effects of circulating oxytocin on food intake in male rats. Endocrinology 155:2845-57
Meek, Thomas H; Matsen, Miles E; Damian, Vincent et al. (2014) Role of melanocortin signaling in neuroendocrine and metabolic actions of leptin in male rats with uncontrolled diabetes. Endocrinology 155:4157-67
Rojas, J M; Schwartz, M W (2014) Control of hepatic glucose metabolism by islet and brain. Diabetes Obes Metab 16 Suppl 1:33-40
Morton, Gregory J; Meek, Thomas H; Schwartz, Michael W (2014) Neurobiology of food intake in health and disease. Nat Rev Neurosci 15:367-78
Aston-Mourney, Kathryn; Subramanian, Shoba L; Zraika, Sakeneh et al. (2013) One year of sitagliptin treatment protects against islet amyloid-associated *-cell loss and does not induce pancreatitis or pancreatic neoplasia in mice. Am J Physiol Endocrinol Metab 305:E475-84
Diaferia, Giuseppe R; Jimenez-Caliani, Antonio J; Ranjitkar, Prerana et al. (2013) *1 integrin is a crucial regulator of pancreatic *-cell expansion. Development 140:3360-72

Showing the most recent 10 out of 75 publications